![David Domzalski](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
David Domzalski
Vorstandsvorsitzender bei
VYNE THERAPEUTICS
Vermögen: 226 010 $ am 30.06.2026
Profil
Mr. David Domzalski is a President, Chief Executive Officer & Director at VYNE Therapeutics, Inc. He is on the Board of Directors at VYNE Therapeutics, Inc. Mr. Domzalski was previously employed as a President, Chief Executive Officer & Director by Menlo Therapeutics, Inc., a Chief Executive Officer & Director by VYNE Pharmaceuticals Ltd., a Vice President-Sales & Marketing by Leo Pharma, Inc., a Senior Vice President & General Manager by Azur Pharma, Inc., a Vice President-Sales & Marketing by Warner Chilcott, Inc., and a Vice President by Sanofi-Synthelabo, Inc. He received his undergraduate degree from Muhlenberg College.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 23.07.2026 | 347’174 ( 1.04% ) | 226 010 $ | 30.06.2026 |
Aktive Positionen von David Domzalski
| Unternehmen | Position | Beginn |
|---|---|---|
| VYNE THERAPEUTICS | Vorstandsvorsitzender | 01.03.2020 |
Ehemalige bekannte Positionen von David Domzalski
| Unternehmen | Position | Ende |
|---|---|---|
VYNE Pharmaceuticals Ltd.
 VYNE Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Develops and manufactures pharmaceutical products for dermatology, gynecology, wounds and burns and ophthalmic disorders | Vorstandsvorsitzender | 09.03.2020 |
Leo Pharma, Inc.
 Leo Pharma, Inc. Drugstore ChainsRetail Trade Wholesales drugs and sundries | Vertrieb & Marketing | 01.07.2013 |
Jazz Pharmaceuticals Commercial Corp.
 Jazz Pharmaceuticals Commercial Corp. Pharmaceuticals: MajorHealth Technology Provides pharmaceutical services | Corporate Officer/Principal | 01.01.2009 |
Warner Chilcott, Inc.
 Warner Chilcott, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures drugs | Vertrieb & Marketing | 01.01.2008 |
| VYNE THERAPEUTICS | Vorstandsvorsitzender | - |
Ausbildung von David Domzalski
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
17
Beziehungen ersten Grades
8
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 8 |
|---|---|
VYNE Pharmaceuticals Ltd.
VYNE Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Develops and manufactures pharmaceutical products for dermatology, gynecology, wounds and burns and ophthalmic disorders | Health Technology |
Menlo Therapeutics, Inc.
 Menlo Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Engages in development and commercialization of serlopitant products | Health Technology |
Muhlenberg College
 Muhlenberg College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Warner Chilcott, Inc.
Warner Chilcott, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures drugs | Health Technology |
Sanofi-Synthelabo, Inc. | Health Technology |
Jazz Pharmaceuticals Commercial Corp.
Jazz Pharmaceuticals Commercial Corp. Pharmaceuticals: MajorHealth Technology Provides pharmaceutical services | Health Technology |
Leo Pharma, Inc.
Leo Pharma, Inc. Drugstore ChainsRetail Trade Wholesales drugs and sundries | Retail Trade |
VYNE Therapeutics, Inc.
 VYNE Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures pharmaceutical products | Health Technology |
